Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AKYA

Akoya BioSciences (AKYA)

Akoya BioSciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AKYA
DateTimeSourceHeadlineSymbolCompany
05/13/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AKYAAkoya BioSciences Inc
05/13/20243:00PMGlobeNewswire Inc.Akoya Biosciences Reports First Quarter 2024 Financial ResultsNASDAQ:AKYAAkoya BioSciences Inc
05/09/20247:00AMGlobeNewswire Inc.Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma PatientsNASDAQ:AKYAAkoya BioSciences Inc
05/06/20247:00AMGlobeNewswire Inc.Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, MassachusettsNASDAQ:AKYAAkoya BioSciences Inc
05/02/20247:00AMGlobeNewswire Inc.Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical WorkflowsNASDAQ:AKYAAkoya BioSciences Inc
04/22/20243:05PMGlobeNewswire Inc.Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024NASDAQ:AKYAAkoya BioSciences Inc
04/05/20247:00AMGlobeNewswire Inc.Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and ScaleNASDAQ:AKYAAkoya BioSciences Inc
03/04/20244:18PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AKYAAkoya BioSciences Inc
03/04/20243:05PMGlobeNewswire Inc.Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial OutlookNASDAQ:AKYAAkoya BioSciences Inc
03/04/20245:01AMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:AKYAAkoya BioSciences Inc
03/01/20248:58PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKYAAkoya BioSciences Inc
03/01/20248:58PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKYAAkoya BioSciences Inc
03/01/20248:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKYAAkoya BioSciences Inc
03/01/20248:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKYAAkoya BioSciences Inc
03/01/20248:52PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKYAAkoya BioSciences Inc
03/01/20248:52PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKYAAkoya BioSciences Inc
03/01/20248:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKYAAkoya BioSciences Inc
02/12/20248:11AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AKYAAkoya BioSciences Inc
02/08/20243:05PMGlobeNewswire Inc.Akoya to Report Fourth Quarter and Full Year 2023 Financial Results on March 4th, 2024 and Participate at an Upcoming Investor ConferenceNASDAQ:AKYAAkoya BioSciences Inc
01/18/20247:00AMGlobeNewswire Inc.Akoya Biosciences’ Technology Enables Queensland Spatial Biology Centre to Revolutionize the Diagnosis and Treatment of Cancer and Other DiseasesNASDAQ:AKYAAkoya BioSciences Inc
01/10/20243:02PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AKYAAkoya BioSciences Inc
01/10/20247:00AMGlobeNewswire Inc.Akoya Biosciences Announces that Garry Nolan, Ph.D., James Allison, Ph.D., and Padmanee Sharma, M.D., Ph.D., Join Newly Created Scientific Advisory BoardNASDAQ:AKYAAkoya BioSciences Inc
01/08/20242:57PMDow Jones NewsAkoya Biosciences Shares Jump on 2024 Outlook, Thermo Fisher DealNASDAQ:AKYAAkoya BioSciences Inc
01/08/20245:02AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AKYAAkoya BioSciences Inc
01/07/20247:00AMGlobeNewswire Inc.Akoya Biosciences Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2023 and Provides 2024 OutlookNASDAQ:AKYAAkoya BioSciences Inc
01/07/20247:00AMGlobeNewswire Inc.Akoya Biosciences and Thermo Fisher Scientific Announce a License and Distribution Agreement to Deliver Spatial Multiomics WorkflowNASDAQ:AKYAAkoya BioSciences Inc
01/07/20247:00AMGlobeNewswire Inc.Akoya Biosciences Deploys the MaxFuse Algorithm Co-Developed by Dr. Garry Nolan and His Laboratory at Stanford University for Multiomic Integration of Spatial and Single-cell Data on the Enable Medicine PlatformNASDAQ:AKYAAkoya BioSciences Inc
01/03/20247:50AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AKYAAkoya BioSciences Inc
12/20/20236:16PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKYAAkoya BioSciences Inc
12/20/20237:05AMGlobeNewswire Inc.Akoya to Participate at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:AKYAAkoya BioSciences Inc
 Showing the most relevant articles for your search:NASDAQ:AKYA